Kadın cinsel işlev bozukluğu yönetiminde güncel yaklaşımlar ve kanıt temelli uygulamalar

Kadın cinsel işlev bozukluğu genellikle cinsel ilgi/uyarılmada azalma, orgazmik bozukluk ve cinsel ilişki sırasında ortaya çıkan ağrı ile karakterize psikofizyolojik bozukluklar olarak tanımlanmaktadır. Kadınlar üzerinde ekonomik, psikolojik, kişilerarası zorlukluğa neden olan, yaşamın tüm yönleri üzerinde olumsuz sonuçları olan çok faktörlü bir sorundur. Etiyolojisinin çeşitliliği nedeniyle standart bir tedavi uygulanamamaktadır. Tedavinin yönünü belirlemek amacıyla altta yatan nedenlerin incelenmesi ve kanıta dayalı uygulamalar çerçevesinde en uygun tedaviye karar verilmesi gerekmektedir. Bu nedenle derleme kadınlarda cinsel işlev bozukluğunun yönetiminde kullanılan güncel yaklaşımlar ve kanıt temelli uygulamaların incelenmesi amacıyla yapılmıştır.

Current approaches and evidence based practices in female sexual dysfunction management

Female sexual dysfunction is defined generally as psychophysiological disorders characterized by decreased sexual interest/arousal, orgasmic disorder, and pain during sexual intercourse. It is a multi-factor problem that causes economic, psychological, interpersonal difficulties for women and has negative consequences on all aspects of life. Due to the diversity of its etiology, a standard treatment is not available. In order to determine the direction of treatment, the underlying causes should be examined and the most appropriate treatment should be decided within the framework of evidence based practices. This review aims to examine current approaches and evidence based practices used in the management of sexual dysfunction in women.

Kaynakça

1. Bilgin Z, Kömürcü N. Kadın cinselliği ve kanıt temelli yaklaşımlar. Androloji Bülteni 2016;18:48–55. https://jag.journalagent.com/ androloji/pdfs/AND_18_64_48_55.pdf

2. Shifren JL. Overview of sexual dysfunction in women: Management. UpToDate 2019. https://www.uptodate.com/ contents/overview-of-sexual-dysfunction-in-women-management

3. WHO. Sexual health 2019. https://www.who.int/topics/sexual_ health/en/

4. Thomas HN, Thurston RC. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: A narrative review. Maturitas 2016;87:49–60. [CrossRef]

5. Akarsu R, Beji NK. Kadın cinsel fonksiyon bozuklukları sınıflandırılmasında DSM-V kapsamında yapılan değişiklikler. Androloji Bülteni 2016;18:134–7. https://jag.journalagent.com/ androloji/pdfs/AND_18_65_134_137.pdf

6. Yilmaz BA, Sonmez Y, Sezik M. Prevalence and risk factors for sexual dysfunction in reproductive-aged married women: A cross-sectional epidemiological study. J Obstet Gynaecol Res 2020;46:507–16. [CrossRef]

7. Uslu E, İnfal S, Ulusoy MN. Cinsel sorunların çözümünde Plissit modelinin etkisi. Psikiyatride Güncel Yaklaşımlar 2016;8:52–63. [CrossRef]

8. Tehrani FR, Farahmand M, Simbar M, Afzali HM. Factors associated with sexual dysfunction; a population based study in Iranian reproductive age women. Arch Iran Med 2014;17:679–84. http://www.ams.ac.ir/AIM/NEWPUB/14/17/10/008.pdf

9. Çayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int 2004;72:52–57. [CrossRef]

10. Cayan, S, Yaman Ö, Orhan İ, Usta M, Başar M, Resim S, et al. Prevalence of sexual dysfunction and urinary incontinence and associated risk factors in Turkish women. Eur J Obstet Gynecol Reprod Biol 2016;203:303–8. [CrossRef]

11. Küçükdurmaz F, Efe E, Malkoc O, Kolus E, Amasyali AS, Resim S. Prevalence and correlates of female sexual dysfunction among Turkish pregnant women. Turk J Urol 2016;42:178–83. [CrossRef]

12. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 2006;175:654–58. [CrossRef]

13. Khajehei M, Doherty M, Tilley PJM. An update on sexual function and dysfunction in women. Arch Women’s Ment Health 2015;18:423–33. [CrossRef]

14. Lowth M. Female Sexual Dysfunction. NICE (National Institute for Health and Care Excellence). Patient 2017. https://patient. info/doctor/female-sexual-dysfunction-pro

15. Jha S, Thakar R. Female sexual dysfunction. Eur J Obstet Gynecol Reprod Biol 2010;153:117–23. [CrossRef]

16. Raina R, Pahlajani G, Khan S, Gupta S, Agarwal A, Zippe CD. Female sexual dysfunction: classification, pathophysiology, and management. Fertil Steril 2007;88:1273–84. [CrossRef]

17. Sharma JB, Kalra B. Female sexual dysfunction: Assessment. J Pak Med Assoc 2016;66:623–6.

18. Starc A, Jukić T, Poljšak B, Dahmane R. Female Sexual Function and Dysfunction: A Cross-National Prevalence Study in Slovenia. Acta Clinica Croatica 2018;57:52–60. [CrossRef]

19. Safdar F, Eng CLJ, Wai KL, Tey WS, Ang SB. Prevalence of female sexual dysfunction in allied health workers: a cross-sectional pilot study in a tertiary hospital in Singapore. BMC Women’s Health 2019;19:137. [CrossRef]

20. McCool ME, Zuelke A, Theurich MA, Knuettel H, Ricci C, Apfelbacher C. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies. Sex Med Rev 2016;4:197–212. [CrossRef]

21. Faubion SS, Rullo JE. Sexual Dysfunction in Women: A Practical Approach. Am Fam Physician 2015;92:281–8. https://www.aafp. org/afp/2015/0815/afp20150815p281.pdf

22. McCool-Myers M, Theurich M, Zuelke A, Knuettel H, Apfelbacher C. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Women’s Health 2018;18:108. [CrossRef]

23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5® ) 2013: American Psychiatric Publications. https://www.psychiatry.org/psychiatrists/practice/ dsm

24. Tuğut N. Cinsel İşlev Bozukluğu ve Güncel Yaklaşımlar. Turkiye Klinikleri J Obstet Women’s Health Dis Nurs - Special Topics 2016;2:70–5. https://www.researchgate.net/ publication/322303560_Cinsel_Islev_Bozuklugu_ve_Guncel_ Yaklasimlar

25. Both S. Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder. Curr Sex Health Rep 2017;9:192–9. [CrossRef]

26. Dubé JP, Corsini-Munt S, Muise A, Rosen NO. Emotion Regulation in Couples Affected by Female Sexual Interest/Arousal Disorder. Arch Sex Behav 2019;48:2491–506. [CrossRef]

27. Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women’s sexual desire and arousal disorders. J Sex Med 2010;7:586–614. [CrossRef]

28. Brotto LA, Chivers ML, Millman RD, Albert A. Mindfulnessbased sex therapy improves genital-subjective arousal concordance in women with sexual desire/arousal difficulties. Arch Sex Behav 2016;45:1907–21. [CrossRef]

29. Lamont J, Bajzak K, Bouchard C, Burnett M, Byers S, Cohen T, et al. No 279-Female Sexual Health Consensus Clinical Guidelines. J Obstet Gynaecol Canada 2018;40:e451–503. [CrossRef]

30. Jaderek I, Lew-Starowicz M. A Systematic Review on Mindfulness Meditation-Based Interventions for Sexual Dysfunctions. J Sex Med 2019;16:1581–96. [CrossRef]

31. Krakowsky Y, Grober ED. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada. Canadian Urol Assoc J 2018;12:211–6. [CrossRef]

32. Weinberger JM, Houman J, Caron AT, Anger J. Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities. Sex Med Rev 2018;7:223–50. [CrossRef]

33. Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician 2000;62:127–36. https://www.aafp.org/ afp/2000/0701/p127.html

34. Yeni E. Kadın cinsel fonksiyon bozukluklarında kanıta dayalı tedavi seçenekleri. Androloji Bülteni 2019;21:185–9. [CrossRef]

35. Chen CH, Lin YC, Chiu LH, Chu YH, Ruan FF, Liu WM, Wang PH. Female sexual dysfunction: definition, classification, and debates. Taiwanese J Obstet Gynecol 2013;52:3–7. [CrossRef]

36. Zarski AC, Berking M, Ebert DD. Efficacy of Internet-Based Guided Treatment for Genito-Pelvic Pain/Penetration Disorder: Rationale, Treatment Protocol, and Design of a Randomized Controlled Trial. Front Psychiatry 2018;8:260. [CrossRef]

37. Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol 2009;60:70–6. [CrossRef]

38. ACOG, Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol 2019;134:e1–18. [CrossRef]

39. Öztürk CŞ. Cinsel İşlev Bozukluklarına Yönelik Psikolojik Müdahaleler. Yeni Symposium 2019;57:18–28. http:// yenisymposium.com/Pdf/TR-YeniSempozyum-71be9fc8.pdf

40. Berner MM, Günzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions--a systematic review of controlled clinical trials: part 2--the efficacy of psychosocial interventions for female sexual dysfunction. J Sex Med 2012;9:3108–25. [CrossRef]

41. Bradford A. Female orgasmic disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate 2017. https://www.uptodate.com/contents/ female-orgasmic-disorder-epidemiology-pathogenesis-clinicalmanifestations-course-assessment-and-diagnosis

42. Rellini AH, Clifton J. Female Orgasmic Disorder. Adv Psychosom Med 2011;31:35–56. [CrossRef]

43. İncesu C. Cinsel işlevler ve cinsel işlev bozuklukları. Klinik Psikiyatri Derg 2004;7:3–13. https://www.journalagent.com/kpd/ pdfs/KPD_7_70_3_13.pdf

44. Piassarolli VP, Hardy E, de Andrade NF, de Oliveira Ferreira N, Osis MJD. Pelvic floor muscle training in female sexual dysfunctions. Rev Bras Ginecol Obstet 2010;32:234–40. [CrossRef]

45. Fooladi E, Davis SR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother 2012;13:2131–42. [CrossRef]

Kaynak Göster